Skip Navigation


IJE Advance Access originally published online on February 14, 2008
International Journal of Epidemiology 2008 37(2):225-230; doi:10.1093/ije/dyn016
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/2/225    most recent
dyn016v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ebrahim, S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ebrahim, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press on behalf of the International Epidemiological Association © The Author 2008; all rights reserved.

Editorial

Chronic diseases and calls to action

Shah Ebrahim

London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, UK.

E-mail: shah.ebrahim@lshtm.ac.uk

Accepted 14 January 2008

The first 150 words of the full text of this article appear below.

Hold the front page! ‘Chronic diseases, principally cardiovascular diseases (CVDs), cancer, chronic respiratory diseases, and diabetes, are leading causes of death and disability but are grossly neglected on the global-health agenda’ announced the Lancet on 8 December 2007.1 This was true 2 years ago in 2005 when the Lancet highlighted the general neglect of chronic diseases in the face of Millennium Development Goals resolutely focused on child and maternal survival.2, 3 Indeed chronic diseases have topped infectious diseases in the global death league since the first report from the global burden of disease project in 1990.4

An important but completely neglected aspect of the discussion is that the rise in chronic disease burden represents an increase in the population at risk resulting from successful implementation of maternal and child health programmes in the developing world—a theme I will return to.

Will a campaign of ‘international science advocacy’ led by the . . . [Full Text of this Article]

Is it affordable?

Is it clinically relevant?

We are all going to die!

Prioritization: too many calls for action?

Is the message clear?

Why isn't the North Karelia approach being promoted?


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Int J EpidemiolHome page
S. Ebrahim
The riches of cohorts
Int. J. Epidemiol., April 1, 2008; 37(2): 223 - 224.
[Full Text] [PDF]